发明名称 REMEDIES FOR LIVER DISEASES, HYPERLIPEMIA AND DIABETES
摘要 Agents for treating and preventing hepatopathies, hyperlipemia and/or diabetes comprise a peptide composed of L-amino acids constituting natural proteins, having a L-glutamine content of 15-60 weight% and having an average molecular weight of 200-100000. ACTIVITY : Hepatotropic; Antilipemic; Antidiabetic; Antiinflammatory; Virucide. In a volunteer with fatty liver administration of a glutamine peptide (GP-1; average molecular weight = 7000; L-glutamine content is 32 weight%) at 9.9 g/day after 3 weeks gave glutamic oxaloacetic transaminase levels of 16 IU/l and glutamic pyruvic transaminase levels of 25 IU/l compared to 72 and 124 IU/l respectively at the beginning of the test. MECHANISM OF ACTION : Cholesterol-Antagonist.
申请公布号 EP1481684(A4) 申请公布日期 2008.04.02
申请号 EP20030743531 申请日期 2003.02.28
申请人 NISSHIN PHARMA INC. 发明人 HORIGUCHI, NOBORU;HORIGUCHI, HIROSHI;SUZUKI, YOSHIO
分类号 A21D2/24;A21D2/26;A23J3/34;A23L1/09;A23L1/16;A23L1/305;A23L1/39;A61K38/01;A61K38/16;A61P1/16;A61P3/06;A61P3/10 主分类号 A21D2/24
代理机构 代理人
主权项
地址